Ameritas Investment Partners’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$46.4K Hold
8,747
﹤0.01% 2232
2025
Q1
$77.6K Hold
8,747
﹤0.01% 1867
2024
Q4
$120K Hold
8,747
﹤0.01% 1650
2024
Q3
$240K Hold
8,747
0.01% 1196
2024
Q2
$214K Hold
8,747
0.01% 1219
2024
Q1
$186K Buy
8,747
+720
+9% +$15.4K 0.01% 1339
2023
Q4
$154K Hold
8,027
0.01% 1452
2023
Q3
$129K Buy
8,027
+1,356
+20% +$21.8K 0.01% 1478
2023
Q2
$155K Buy
6,671
+605
+10% +$14K 0.01% 1303
2023
Q1
$141K Hold
6,066
0.01% 1301
2022
Q4
$130K Hold
6,066
0.01% 1404
2022
Q3
$115K Hold
6,066
0.01% 1398
2022
Q2
$110K Hold
6,066
﹤0.01% 1437
2022
Q1
$153K Hold
6,066
0.01% 1359
2021
Q4
$167K Hold
6,066
0.01% 1339
2021
Q3
$196K Buy
6,066
+275
+5% +$8.89K 0.01% 1213
2021
Q2
$177K Hold
5,791
0.01% 1338
2021
Q1
$176K Sell
5,791
-358
-6% -$10.9K 0.01% 1301
2020
Q4
$122K Hold
6,149
0.01% 1452
2020
Q3
$80K Hold
6,149
﹤0.01% 1570
2020
Q2
$70K Hold
6,149
﹤0.01% 1627
2020
Q1
$88K Hold
6,149
0.01% 1350
2019
Q4
$167K Buy
6,149
+334
+6% +$9.07K 0.01% 1209
2019
Q3
$166K Hold
5,815
0.01% 1160
2019
Q2
$162K Hold
5,815
0.01% 1182
2019
Q1
$193K Buy
5,815
+290
+5% +$9.63K 0.01% 1068
2018
Q4
$161K Hold
5,525
0.01% 1078
2018
Q3
$254K Hold
5,525
0.01% 955
2018
Q2
$206K Hold
5,525
0.01% 1054
2018
Q1
$163K Hold
5,525
0.01% 1183
2017
Q4
$190K Hold
5,525
0.01% 1112
2017
Q3
$168K Sell
5,525
-305
-5% -$9.27K 0.01% 1152
2017
Q2
$151K Hold
5,830
0.01% 1207
2017
Q1
$112K Buy
+5,830
New +$112K 0.01% 1354
2016
Q2
Sell
-30,660
Closed -$1.15M 1188
2016
Q1
$1.15M Hold
30,660
0.08% 258
2015
Q4
$1.32M Buy
30,660
+25,300
+472% +$1.09M 0.09% 235
2015
Q3
$201K Buy
+5,360
New +$201K 0.01% 928
2013
Q4
Sell
-21,100
Closed -$495K 1069
2013
Q3
$495K Buy
+21,100
New +$495K 0.05% 521